معرفی
Kevin Du, MD, PhD, is an Associate Professor of Therapeutic Radiology at Yale School of Medicine and Medical Director of the Trumbull Radiation Oncology Center at Smilow Cancer Hospital. He holds an MD and PhD from the University of Pennsylvania, with additional master's training in Clinical Investigation from NYU. Dr. Du is a member of the Yale Cancer Center and leads clinical trials focused on improving cancer outcomes through innovative radiotherapy approaches.
His research interests center on radiation oncology, with specialized expertise in breast cancer radiotherapy, gastrointestinal malignancies, organ preservation techniques, and quality assurance in radiation therapy. Dr. Du's work emphasizes biologically tailored treatments and clinical trial development for challenging cancers like pancreatic and gastric malignancies.
Recent publications demonstrate a strong focus on radiation therapy quality assurance (NRG Oncology RTOG 0848), competency-based medical education (Milestones 2.0), and novel treatment combinations for gastrointestinal cancers. His 15 most recent articles (2018-2024) cluster thematically into: clinical trial quality metrics (35%), radiation oncology education reform (25%), gastrointestinal cancer therapies (25%), and immunoradiation combinations (15%).
Awards and Honors
- Top Doctors, Castle Connolly (2020, 2021, 2022, 2023)
- Top Doctors, New York Magazine (2021)
He currently leads clinical trials including a phase II study of pembrolizumab for head/neck cancer (NCT# not provided) and the MAVERICK trial for small-cell lung cancer. No specific grant, student advising, or lab details were documented in the source materials.